Complications and prognostic factors in Vogt-Koyanagi-Harada disease

American Journal of Ophthalmology

Volumn 131, Issue 5, 2001, Pages 599-606

  Read, Russell W ^a   Rechodouni, Aida ^a   Butani, Neil ^a   Johnston, Richard ^a   LaBree, Laurie D ^a   Smith, Ronald E ^a   Rao, Narsing A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; DISEASE COURSE; EYE INFLAMMATION; FEMALE; FIBROSIS; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGED; CATARACT; CHILD; CHOROIDAL NEOVASCULARIZATION; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETINAL NECROSIS SYNDROME, ACUTE; RETROSPECTIVE STUDIES; RISK FACTORS; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY;

EID: 0035021332     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)00937-0     Document Type: Article

References (25)

1. Moorthy RS, Inomata H, Rao N A. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-292.
2. Numaga J, Matsuki K, Tokunaga K, et al. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 1991;32:1958-1961.
3. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994;78:223-226.
4. Shindo Y, Ohno S, Yamamoto T, et al. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994;39:169-176.
5. Davis JL, Mittal KK, Freidlin V, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 1990;97:1137-1142.
6. Arellanes-Garcia L, Bautista N, Mora P, et al. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocular Immunol Inflamm 1998;6:93-100.
7. Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998;59:183-188.
8. Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35:3890-3896.
9. Islam SM, Numaga J, Matsuki K, et al. Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35:752-756.
10. Weisz JM, Holland GN, Roer LN, et al. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology 1995;102:1012-1015.
11. Davis J. Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry. Am J Ophthalmol 1993;115:688.
12. Rao N A. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 1997;11:213-216.
13. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-687.
14. Forster DJ, Rao NA, Hill RA, et al. Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. Ophthalmology 1993;100:613-618.
15. Moorthy RS, Rajeev B, Smith RE, Rao N A. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1994;118:197-204.
16. Moorthy RS, Chong LP, Smith RE, Rao NA. Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1993;116:164-170.
17. Kuo IC, Rechdouni A, Rao N A, et al. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 2000;107:1721-1728.
18. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980;90:69-75.
19. Read RW, Rao NA. Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis. Ocul Immunol Inflamm 2000;8:227-234.
20. Read R, Holland G, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-652.
21. Minnakawa R, Ohno S, Hirose S, et al. Clinical manifestations of Vogt Koyanagi Harada disease. Jpn J Clin Ophthalmol 1985;39:1249-1253.
22. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32:334-343.
23. Lertsumitkul S, Whitcup SM, Nussenblatt RB, Chan CC. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Graefes Arch Clin Exp Ophthalmol 1999;237:1039-1045.
24. Tabbara KF, Chavis PS, Freeman WR. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998;76:723-726.
25. Rathinam SR, Vijayalakshmi P, Namperumalsamy P, et al. Vogt-Koyanagi-Harada syndrome in children. Ocular Immunol Inflamm 1998;6:155-161.